Quince Therapeutics
QNCX
$0.93
Share price
-2.74%
Change (1 day)
-42.72%
Change (1 year)
Categories
Quince Therapeutics (QNCX) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $82.81 M
According to Quince Therapeutics's latest financial reports the company's total liabilities are $82.81 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Quince Therapeutics - Total liabilities on balance sheet (from 2018 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $3.31 M | -77.35% |
| 2021-12-31 | $14.64 M | -14.89% |
| 2020-12-31 | $17.2 M | 93.48% |
| 2019-12-31 | $8.89 M | -91.57% |
| 2018-12-31 | $0.10 B | 276.82% |
| 2017-12-31 | $27.99 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $27.91 M | -66.29% | 🇺🇸 USA |